Colon cancer blood test offers new screening option
Time:2024-05-21 10:19:49 Source:sportViews(143)
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Previous:Why US Catholics are planning pilgrimages in communities across the nation
Next:Pope trip to Luxembourg, Belgium confirmed for September, 2 weeks after challenging Asia visit
You may also like
- Brazil replaces injured goalkeeper Ederson in Copa America squad
- Democrats warn of Republican meddling in a key Oregon primary
- Democrats warn of Republican meddling in a key Oregon primary
- Moment machete
- 'Constantly learning' Imanaga off to impressive start with the Chicago Cubs
- Moment disqualified hit
- North Carolina lawmakers push bill to ban most public mask wearing, citing crime
- Landlord slammed after gloating about evicting their tenant
- 'The Apprentice,' about a young Donald Trump, premieres in Cannes